🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/02/2022 | 76,85 | 76,93 | 76,00 | 76,36 | -1,11% | 1,21% | 8.889.300 |
| 16/02/2022 | 77,20 | 77,80 | 76,93 | 77,22 | -0,76% | 1,13% | 9.981.300 |
| 15/02/2022 | 77,51 | 78,19 | 77,32 | 77,81 | +1,75% | 1,12% | 11.425.600 |
| 14/02/2022 | 76,63 | 76,70 | 75,11 | 76,47 | -0,22% | 2,07% | 9.881.100 |
| 11/02/2022 | 76,40 | 77,90 | 76,17 | 76,64 | +0,10% | 2,26% | 9.342.300 |
| 10/02/2022 | 76,36 | 76,77 | 75,93 | 76,56 | +0,04% | 1,10% | 12.437.600 |
| 09/02/2022 | 77,17 | 77,33 | 76,41 | 76,53 | -0,49% | 1,19% | 15.183.100 |
| 08/02/2022 | 77,10 | 77,33 | 75,82 | 76,91 | -0,86% | 1,96% | 17.486.500 |
| 07/02/2022 | 78,79 | 78,92 | 77,44 | 77,58 | -1,25% | 1,88% | 23.615.300 |
| 04/02/2022 | 78,51 | 79,55 | 78,20 | 78,56 | -0,57% | 1,72% | 10.716.200 |
| 03/02/2022 | 81,65 | 81,80 | 78,40 | 79,01 | -3,66% | 4,16% | 19.181.400 |
| 02/02/2022 | 81,80 | 82,30 | 81,26 | 82,01 | +0,11% | 1,27% | 13.988.200 |
| 01/02/2022 | 81,96 | 82,12 | 81,08 | 81,92 | +0,54% | 1,27% | 10.803.300 |
| 31/01/2022 | 81,02 | 81,72 | 80,80 | 81,48 | +0,72% | 1,14% | 13.035.000 |
| 28/01/2022 | 79,54 | 80,99 | 79,18 | 80,90 | +0,40% | 2,28% | 13.915.300 |
| 27/01/2022 | 78,42 | 81,60 | 78,42 | 80,58 | +1,82% | 4,06% | 20.187.200 |
| 26/01/2022 | 79,39 | 80,34 | 78,73 | 79,14 | -0,40% | 2,03% | 13.046.600 |
| 25/01/2022 | 78,42 | 79,78 | 77,78 | 79,46 | +0,80% | 2,55% | 13.662.400 |
| 24/01/2022 | 79,77 | 80,11 | 76,65 | 78,83 | -1,44% | 4,34% | 17.289.000 |
| 21/01/2022 | 81,27 | 81,52 | 79,24 | 79,98 | -0,95% | 2,81% | 18.461.700 |
| 20/01/2022 | 80,73 | 81,86 | 80,52 | 80,75 | -0,66% | 1,66% | 12.069.600 |
| 19/01/2022 | 80,98 | 81,98 | 80,48 | 81,29 | -0,31% | 1,85% | 11.448.200 |
| 18/01/2022 | 81,10 | 82,16 | 80,81 | 81,54 | +0,20% | 1,66% | 14.493.100 |
| 14/01/2022 | 81,60 | 81,85 | 80,77 | 81,38 | +0,07% | 1,32% | 9.478.000 |
| 13/01/2022 | 80,93 | 81,72 | 80,33 | 81,32 | +0,15% | 1,72% | 9.678.100 |
| 12/01/2022 | 81,08 | 81,42 | 80,67 | 81,20 | -0,58% | 0,93% | 13.057.000 |
| 11/01/2022 | 82,42 | 82,56 | 80,65 | 81,67 | -0,85% | 2,32% | 11.585.100 |
| 10/01/2022 | 80,54 | 82,45 | 79,67 | 82,37 | +2,58% | 3,45% | 19.636.800 |
| 07/01/2022 | 78,86 | 80,53 | 78,46 | 80,30 | +1,86% | 2,62% | 15.212.000 |
| 06/01/2022 | 78,79 | 79,58 | 77,95 | 78,83 | -0,06% | 2,07% | 11.359.200 |